Please login to the form below

Not currently logged in

Havas Just:: names Nicole Yost chief executive officer

Yost will replace Jennie Talman, who is stepping aside after 15 years

Specialist healthcare communications agency Havas Just:: has named Nicole Yost (pictured above) its new chief executive officer.

Yost will replace Havas Just:: co-founder Jennie Talman, who has been in the CEO role at the agency for 15 years.

While Yost will take the helm at Havas Just::, Talman will act as executive advisor to the agency and will remain involved in client business.

Yost has held leadership roles at Burson Cohn & Wolfe (BCW), Porter Novelli and Ogilvy Healthworld.

Most recently, she was responsible for establishing a new division at BCW, which focused on business transformation in the health sector.

“Havas Just:: has a strong reputation and a distinct personality. I am excited to be part of its future and am also looking forward to getting to know the team as well as my global colleagues in the Havas Health & You network,” commented Yost.

“Right now there is an opportunity to transform the relationship that pharma has with the public. My ambition is for Havas Just:: to play a critical role in helping our clients to shape the post-pandemic conversation around the provision and value of healthcare,” she added.

Article by
Lucy Parsons

20th February 2021

From: Marketing


Subscribe to our email news alerts

Featured jobs


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...
Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...